News Focus
News Focus
Followers 17
Posts 935
Boards Moderated 0
Alias Born 04/09/2015

Re: XenaLives post# 301425

Tuesday, 03/02/2021 2:09:13 PM

Tuesday, March 02, 2021 2:09:13 PM

Post# of 517600
Some of the research on av1066 has to do with alleviating the pain that sometimes accompanies chemotherapy. Lots of possibilities - I wouldn't mind if Dr Missling used the voucher(if we get it) to bring 1066 to trial.

"sigma-1 receptor (S1R) modulation prevents neuropathic pain and mitochondrial abnormalities induced by the chemotherapy drug paclitaxel.

Paclitaxel is a first-line anti-tumor agent that frequently produces neuropathic pain, for which no treatment is available. The lifestyle of patients receiving paclitaxel can be severely impacted and the problem is compounded by the lack of efficacy and frequent incidence of side effects associated with currently available treatments for pain. There is an important therapeutic opportunity for drug candidates that simultaneously fight cancer and prevent pain."


https://www.anavex.com/research-report-confirms-opportunity-for-anavex-anti-cancer-and-neuropathic-pain-compounds/

They said "You should be on the stage!" (As in - the next stage out of town)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News